Students can check MPBSE Class 10 Science exam question paper and answer key 2026 from here. The exam was conducted on February 27, 2026, from 9 AM to 12 PM.

Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance, and production systems and shaping how teams interact with software, how processes are managed, and how work ...

WBBSE 10th Exam 2026: The West Bengal Board of Secondary Education (WBBSE) successfully conducted the West Bengal Madhyamik Life Science Exam 2026 on February 11, 2026, from 10:45 AM to 2:00 PM. As ...

SEATTLE and VANCOUVER, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, ...

After holding its breath for several rough years, Greater Boston’s life sciences sector is cautiously coming up for air. It was a year of devastating uncertainty for the sector and its roughly 75,000 ...

Life sciences dealmaking came back in 2025, and artificial intelligence is poised to drive even more M&A activity in 2026 as companies move from hyping the technology to proving its value in drug ...

The life science automation and robotics market is witnessing rapid expansion as biopharma companies accelerate their shift toward AI-driven research and automated manufacturing systems. Rising demand ...

Thermo Fisher recorded higher third-quarter sales on the back of growth in its life sciences business. The scientific services company reported net income of $1.62 billion, or $4.27 a share, compared ...

Anthropic is launching Claude for Life Sciences, a new model aimed at aiding scientific research. Through integrations with leading life sciences players, the platform will help researchers at every ...

The biotech earned an important fast-track review designation from a major regulator. This should speed the development (and potentially, commercialization) of one of its investigational treatments.

October 09, 2025 - Big Pharma continues its hunt for innovation, and with uncertain market and regulatory conditions, some life sciences companies may be feeling the pressure to make their M&A exit or ...